ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
6.05
6.22
Intervallo Annuale
1.98
6.52
Variazione giornaliera
+7.85%
Variazione Mensile
+59.28%
Variazione di 6 mesi
+71.19%
Variazione Annuale
+202.94%
Chiusura Precedente
5.7 3
Open
6.0 6
Minimo
6.0 5
High
6.2 2
Volume
1 579
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Notizie